219-IL) for 5 days to induce Th1 cell development were stained with Mouse Anti-Human T-bet/TBX21 Monoclonal Antibody (Catalog # MAB53851) followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
F0102B) and Mouse Anti-Human CD4 APC-conjugated Monoclonal Antibody (Catalog #
FAB3791A). Quadrant markers were set based on control antibody staining (Catalog #
MAB002). To facilitate intracellular staining, cells were fixed and permeabilized with FlowX FoxP3 Fixation & Permeabilization Buffer Kit (Catalog #
FC012)." class="big_lightbox">

219-IL) for 5 days to induce Th1 cell development were stained with Mouse Anti-Human T-bet/TBX21 Monoclonal Antibody (Catalog # MAB53851) followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
F0102B) and Mouse Anti-Human CD4 APC-conjugated Monoclonal Antibody (Catalog #
FAB3791A). Quadrant markers were set based on control antibody staining (Catalog #
MAB002). To facilitate intracellular staining, cells were fixed and permeabilized with FlowX FoxP3 Fixation & Permeabilization Buffer Kit (Catalog #
FC012)." alt="Human peripheral blood mononuclear cells (PBMCs) either (A) untreated or (B) treated with Anti-Human IL-4 Polyclonal Antibody (Catalog # AB-204-NA; 20 µg/mL) and 10 ng/mL Recombinant Human IL-12 (Catalog #
219-IL) for 5 days to induce Th1 cell development were stained with Mouse Anti-Human T-bet/TBX21 Monoclonal Antibody (Catalog # MAB53851) followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
F0102B) and Mouse Anti-Human CD4 APC-conjugated Monoclonal Antibody (Catalog #
FAB3791A). Quadrant markers were set based on control antibody staining (Catalog #
MAB002). To facilitate intracellular staining, cells were fixed and permeabilized with FlowX FoxP3 Fixation & Permeabilization Buffer Kit (Catalog #
FC012)." class="big_thumb" />